Pall Launches Minimate EVO Filtration System

Designed to allow high productivity, reproducibility, and simple control compared to stirred-cell technologies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pall Corporation has introduced the next generation of its lab-scale tangential flow filtration (TFF) solutions. The Minimate EVO TFF system is designed to allow high productivity, reproducibility, and simple control compared to stirred-cell technologies. The solution aims to simplify laboratory-scale concentration, desalting, and buffer exchange workflows. Pall’s Minimate system is designed for highly reliable buffer exchange or protein concentration of samples up to 1 liter. According ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters